FORE-SIGHT

Curated by Signal

Cerebral oximetry device

Overview

CASMED has developed tissue oximetry devices. The FORE-SIGHT, a cerebral oximetry device, measures the oxygen levels in the brain in real-time. The device has sensors which emit light penetrating the brain and uses an algorithmic technology to detect and measure the tissue oxygen levels. The device also is connected to an interface for displaying the values. The device is available for adults and pediatric patients.

Key facts

Founded: 1984
Headquarters: Branford, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Brazen
Developer of herbal supplement for PMS relief
Life Sciences TechnologyAustin, United States
Pilleve
Platform for monitoring and screening opioid abuse
Life Sciences TechnologyWinston-salem, United States
MindWare Technologies
Developer of mobile impedance cardiograph for lab-based monitoring of autonomic balance, ECG & others
Life Sciences TechnologyWesterville, United States

About FORE-SIGHT

What does FORE-SIGHT do?

CASMED has developed tissue oximetry devices.

Where is FORE-SIGHT headquartered?

FORE-SIGHT is headquartered in Branford, United States.

When was FORE-SIGHT founded?

FORE-SIGHT was founded in 1984.

Which sector is FORE-SIGHT in?

FORE-SIGHT operates in Life Sciences Technology.

Who are FORE-SIGHT's competitors?

Companies similar to FORE-SIGHT include Brazen, Pilleve, and MindWare Technologies.